Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease
- PMID: 8744553
- DOI: 10.1016/0264-410x(95)00210-r
Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease
Abstract
To construct an effective recombinant Marek's disease virus type 1 (MDV1), we localized a stable insertion site for expression of the Escherichia coli lacZ gene near or within the short inverted repeats of MDV1 strain K554 DNA. A stable recombinant MDV1 was obtained by deleting the junction region between the short unique sequence (Us) and the internal short inverted repeat (IRs). The recombinant MDV1 replicated in cultured cells as well as the parental viral DNA. Antibodies against both MDV1 antigen and beta-galactosidase encoded by the lacZ gene were detected in the sera of chickens immunized with the virus, and persisted for at least 16 weeks. Moreover, the recombinant virus conferred protection upon chickens against a challenge with virulent MDV1. These results demonstrated that the Us-IRs junction region is an effective site for the insertion of foreign genes from which to construct a polyvalent live vaccine for poultry. Analysis of the Us-IRs junction region which was deleted from the parental MDV1 indicated that there is a tandem direct repeat of a 220-bp exists within the short internal and terminal inverted repeats of avirulent MDV1 K554 strain DNA. The 220-bp sequence was well conserved among DNAs from various strains. The number of the repeat units may differ between the IRs and TRs or among various MDV1 strain DNAs.
Similar articles
-
Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens.Virology. 1993 Jul;195(1):140-8. doi: 10.1006/viro.1993.1354. Virology. 1993. PMID: 8391181
-
Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.Vaccine. 1994 Aug;12(10):953-7. doi: 10.1016/0264-410x(94)90040-x. Vaccine. 1994. PMID: 7975837
-
Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.Sci Rep. 2016 Dec 16;6:39263. doi: 10.1038/srep39263. Sci Rep. 2016. PMID: 27982090 Free PMC article.
-
History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.Avian Dis. 2016 Dec;60(4):715-724. doi: 10.1637/11429-050216-Hist. Avian Dis. 2016. PMID: 27902902 Review.
-
Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):78-86. doi: 10.1016/j.vetimm.2006.03.014. Epub 2006 May 8. Vet Immunol Immunopathol. 2006. PMID: 16682084 Review.
Cited by
-
Insertion of tandem direct repeats consisting of avian leukosis virus LTR sequences into the inverted repeat region of Marek's disease virus type 1 DNA.Virus Genes. 1997;14(2):157-62. doi: 10.1023/a:1007925519587. Virus Genes. 1997. PMID: 9237356
-
Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.J Virol. 2000 Apr;74(7):3217-26. doi: 10.1128/jvi.74.7.3217-3226.2000. J Virol. 2000. PMID: 10708438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources